The economic value of food labels: A lab experiment on safer infant milk formula



Table 4. Testing for the ambiguity and information effect

Hypothesis1

Test

p-Value

Description

Effect

Wilcoxon’s

0.436

5th trial versus 5th

Cannot reject H0. No

signed-rank test

trial

significant ambiguity

Both        Both

H 0 : FUnclear = FClear

effect.

Wilcoxon’s
signed-rank test

0.013**

5th trial versus 1st

H0 can be rejected at the

trial

0.05 significance level.
Ambiguity effect present.

H :FUnclear = F Both

Kolmogorov-

0.303

5th trial versus 5th

Cannot reject H0. No

0 : Unclear = Unclear

Smirnov two-

trial

significant ambiguity

sample test

effect.

Unclear      Both

/ / y~1 ∣~l 1-, ∣~l 1-,

Kolmogorov-

0.247

5th trial versus 5th

Cannot reject H0. No

0 : Pr ep = Pr ep

Smirnov two-

trial

significant ambiguity

sample test

effect.

Clear      Both

Kolmogorov-

0.111

5th trial versus 5th

Cannot reject H0. No

0 : Clear = Clear

Smirnov two-

trial

significant ambiguity

sample test

effect.

Clear      Both

Kolmogorov-

0.077*

5th trial versus 5th

H0 can be rejected at the

0 : Pr ep = Pr ep

Smirnov two-

trial

0.10 significance level.

sample test

Ambiguity effect present.

Clear      Unclear

Kolmogorov-

0.292

5th trial versus 5th

Cannot reject H0. No

0 : Clear = Unclear

Smirnov two-

trial

significant ambiguity

sample test

effect.

Clear      Unclear

Kolmogorov-

0.163

5th trial versus 5th

Cannot reject H0. No

0 : Prep = Prep

Smirnov two-

trial

significant ambiguity

sample test

effect.

Both      Both

H0 : FClear = FPr ep

Wilcoxon’s
signed-rank test

0.000***

5th trial versus 5th
trial

H0 can be rejected at the
0.01 significance level.

Clear      Clear

H0 : FClear = FPr ep

Wilcoxon’s
signed-rank test

0.000***

5th trial versus 5th
trial

Significant information
effect present.

Unclear      Unclear

H0 : FUnclear = FPr ep

Wilcoxon’s

0.005***

5th trial versus 5th

H0 can be rejected at the

signed-rank test

trial

0.01 significance level.
Significant information

effect present.

Notes: 1Superscript = treatment, Subscript = trial, ***Significance level = 0.01/ ** Significance level =
0.05/ * Significance level = 0.10

10



More intriguing information

1. The name is absent
2. Alzheimer’s Disease and Herpes Simplex Encephalitis
3. Developmental changes in the theta response system: a single sweep analysis
4. TECHNOLOGY AND REGIONAL DEVELOPMENT: THE CASE OF PATENTS AND FIRM LOCATION IN THE SPANISH MEDICAL INSTRUMENTS INDUSTRY.
5. The name is absent
6. Internationalization of Universities as Internationalization of Bildung
7. The name is absent
8. The Role of State Trading Enterprises and Their Impact on Agricultural Development and Economic Growth in Developing Countries
9. The Challenge of Urban Regeneration in Deprived European Neighbourhoods - a Partnership Approach
10. The name is absent
11. GOVERNANÇA E MECANISMOS DE CONTROLE SOCIAL EM REDES ORGANIZACIONAIS
12. The name is absent
13. The name is absent
14. Firm Closure, Financial Losses and the Consequences for an Entrepreneurial Restart
15. Ex post analysis of the regional impacts of major infrastructure: the Channel Tunnel 10 years on.
16. Behaviour-based Knowledge Systems: An Epigenetic Path from Behaviour to Knowledge
17. Fiscal Reform and Monetary Union in West Africa
18. Macroeconomic Interdependence in a Two-Country DSGE Model under Diverging Interest-Rate Rules
19. The name is absent
20. A Bayesian approach to analyze regional elasticities